A sweeping new review of ADHD treatments—drawing on more than 200 meta-analyses—cuts through years of mixed messaging and hype. To make sense of it all, researchers have launched an interactive, ...
CHRYSALIS-2: A phase 1/1b study of lazertinib as monotherapy and in combination with amivantamab in patients with EGFR-mutant NSCLC. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting ...
Bartik, Alexander, Zoë Cullen, Edward L. Glaeser, Michael Luca, and Christopher Stanton. "The Rise of Remote Work: Evidence on Productivity and Preferences from Firm and Worker Surveys." Journal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results